{"schema_version":"secwatch.filing_event.v1","accession":"0001933414-23-000024","form_type":"8-K","ticker":"MLYS","cik":"0001933414","company_name":"Mineralys Therapeutics, Inc.","filed_at":"2023-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.465804+00:00","generated_at":"2026-06-17T21:45:43.248479+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Mineralys Therapeutics discloses 2022 executive bonuses and raises 2023 target bonus percentages","bullets":["2022 bonuses: CEO Congleton $193.2k, CFO Levy $190.9k, CMO Rodman $190.8k.","2023 target bonuses increased: Congleton 50% of base salary, Rodman 45%, Levy 40%.","Revised Summary Compensation Table includes previously omitted 2022 bonus amounts.","Equity awards in 2022: Congleton $1.12M stock, Levy $483.5k stock, Rodman $492k options."],"urls":{"canonical":"https://secwatch.observer/filing/0001933414-23-000024","json":"https://secwatch.observer/filing/0001933414-23-000024.json","markdown":"https://secwatch.observer/filing/0001933414-23-000024.md","text":"https://secwatch.observer/filing/0001933414-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1933414/000193341423000024/0001933414-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1933414/000193341423000024/mlys202303178k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:45:43.248479+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}